All oral sofosbuvir-based antiviral therapy in liver transplant recipients affected by moderate-severe hepatitis C recurrence: Predictors of viral response and survival. (10th February 2016) - Arese, D.; Martini, S.; Sacco, M.; Strona, S.; Cocchis, D.; Mirabella, S.; Rizza, G.; Ottobrelli, A.; Torrani-Cerenzia, M.R.; Balzola, F.; Magistroni, P.; Moschini, P.; et al.